← All organizations
Highest phase reached
Phase 4
First clinical trial
Mar 1, 2016Last known activity
Sep 1, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (18 distinct, 12 trials)
Phase 4 (8 own, 0 via acquisition)
Phase 3 (4 own, 0 via acquisition)
Other trials (6 own, 0 via acquisition)
Indications
Recent trials (17)
- NCT07153744CollaboratorPhase 4Sep 1, 2025
- NCT06823180Lead sponsorPhase 4Mar 1, 2025
- NCT06823180Sponsor investigatorPhase 4Mar 1, 2025
- NCT06538883CollaboratorN/AAug 1, 2024
- NCT06569108OfficialPhase 3Apr 1, 2024
- NCT06312475OfficialPhase 3Jan 9, 2024
- NCT05925166Overall official - principal investigatorN/ASep 1, 2023
- NCT05925166Sponsor investigatorN/ASep 1, 2023
- NCT05925166Lead sponsorN/ASep 1, 2023
- NCT05965687CollaboratorPhase 3Aug 17, 2023
- NCT05488327Lead sponsorN/AAug 1, 2022
- NCT05488327Overall official - principal investigatorN/AAug 1, 2022
- NCT05488327Reponsible party - principal investigatorN/AAug 1, 2022
- NCT04727034CollaboratorN/AMar 2, 2021
- NCT03984760Overall official - principal investigatorPhase 3Jun 30, 2019
Details
- Last known activity
- Sep 1, 2025